ADVFN

toffeeman 18/2/2025 08:29 Read Full Thread Reply Should get full allottment so as long as EIS is forthcoming it will be v good Read Full Thread Reply
toffeeman 14/2/2025 11:10 Read Full Thread Reply I have applied - to try and get my average price below 9p! Read Full Thread Reply
timbo003 14/2/2025 10:49 Read Full Thread Reply I am in for a few more shares in the placing (EIS qualifying). Some reasonable director participation this time which adds to confidence: Read Full Thread Reply
shearluc 11/2/2025 18:06 Read Full Thread Reply Huge fan of GENI, and they will do very well, but surely they are running very low on cash right now? Read Full Thread Reply
toffeeman 11/2/2025 16:55 Read Full Thread Reply and i'll still be sitting on a loss! Read Full Thread Reply
karimgrant 11/2/2025 13:54 Read Full Thread Reply By 2026, it'll be in the 20's or 30's sp Read Full Thread Reply
karimgrant 11/2/2025 13:51 Read Full Thread Reply Well cheap with fda approval about to happen, not to mention the sales of kits now and going forward. A hearty lift Read Full Thread Reply
soulac1 29/1/2025 07:20 Read Full Thread Reply Morning using deepseek, is will get a lot of interest, this the company that wiped billions of the stock market.Cykel AI PLC("Cykel AI" or the "Company")Cykel AI Announces Integration of DeepSeek R1, Reducing AI Costs up to 96% Read Full Thread Reply
oapknob1 28/1/2025 16:12 Read Full Thread Reply The DaVinci Code ? Read Full Thread Reply
darmz 24/1/2025 14:56 Read Full Thread Reply Has anyone cracked the code Read Full Thread Reply
oapknob1 24/1/2025 13:00 Read Full Thread Reply Need funding Read Full Thread Reply
zen12 24/1/2025 09:17 Read Full Thread Reply Seller out...lift off! Read Full Thread Reply
pk83 24/1/2025 08:07 Read Full Thread Reply That's my take I'm building here again Read Full Thread Reply
z1co 23/1/2025 22:26 Read Full Thread Reply Brilliant article in the Daily Mail Market Report STOCK WATCH Read Full Thread Reply
z1co 23/1/2025 17:07 Read Full Thread Reply Delayed buy of 182,040 @ 5.49 from 3.59pm gone through after the close. The news was exceptional , hence the RISE to over 8.5p. 8p to 10p over the coming days Read Full Thread Reply
supertag 23/1/2025 16:19 Read Full Thread Reply Happy with my 101% profit today😊 Read Full Thread Reply
zen12 23/1/2025 16:07 Read Full Thread Reply Looks like that's order filled dyor Read Full Thread Reply
zen12 23/1/2025 16:06 Read Full Thread Reply Double bottom hit Read Full Thread Reply
gopher1981 23/1/2025 16:04 Read Full Thread Reply Like every other penny stock share on LSE will drop back Read Full Thread Reply
z1co 23/1/2025 15:56 Read Full Thread Reply Was over 8.5p mid morning , will keep rising over the coming days Read Full Thread Reply
zen12 23/1/2025 15:41 Read Full Thread Reply Bargain price, you could not touch these at these levels in the morning! Read Full Thread Reply
gopher1981 23/1/2025 15:31 Read Full Thread Reply That didn't age well Read Full Thread Reply

Showing 276 to 297 of 300 messages

GENinCode PLC Holding(s) in Company

GENinCode PLC 06 March 2025 TR-1: Standard form for notification of major holdings 1. Issuer Details ISIN GB00BL97B504 Issuer Name GENINCODE...

GENinCode PLC Holding(s) in Company

GENinCode PLC 05 March 2025 TR-1: Standard form for notification of major holdings 1. Issuer Details ISIN GB00BL97B504 Issuer Name GENINCODE...

GENinCode PLC Holding(s) in Company

GENinCode PLC 04 March 2025 TR-1: Standard form for notification of major holdings 1. Issuer Details ISIN GB00BL97B504 Issuer Name GENINCODE...

GENinCode PLC Result of General Meeting, Issue of Equity and TVR

GENinCode PLC 03 March 2025 3 March 2025 GENinCode Plc ("GENinCode" or the "Company") Result of General Meeting, Issue of Equity and...

GENinCode PLC Result of Retail Offer

GENinCode PLC 18 February 2025 THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION FOR THE PURPOSES OF ARTICLE 7 OF THE MARKET ABUSE REGULATION (EU...

IN BRIEF: GENinCode raises GBP4.0 million via placing and subscription

xford, England-based genomic testing company focused on the prevention of cardiovascular disease - Raises GBP4.0 milli ...

GENinCode PLC Result of Placing and Subscription

GENinCode PLC 14 February 2025 NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN WHOLE OR IN PART, IN OR INTO OR WITHIN...

GENinCode PLC Retail Offer

GENinCode PLC 14 February 2025 THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION FOR THE PURPOSES OF ARTICLE 7 OF THE MARKET ABUSE REGULATION (EU...

GENinCode PLC Placing and Subscription

GENinCode PLC 14 February 2025 THIS ANNOUNCEMENT, INCLUDING THE APPENDICES, AND THE INFORMATION CONTAINED HEREIN, IS RESTRICTED AND NOT FOR...

GENinCode shares rally on test inclusion in clinical lab fee schedule

GENinCode PLC on Thursday saw its share price more than double as it reported key developments relating to its Cardio ...

GENinCode PLC CARDIO inCode Lab Fee Update & Catalonia Launch

GENinCode PLC 23 January 2025 23 January 2025 GENinCode Plc ("GENinCode" or the "Company") CARDIO inCode® inclusion in the US CMS 2025...

GENinCode PLC Partnership with Genesupport SA for the ROCA® Test

GENinCode PLC 10 December 2024 GENinCode Plc ("GENinCode" or the "Company") GENinCode partners with Genesupport SA for the ROCA® Test in...

GENinCode PLC CARDIO inCode® publication & Trading Update

GENinCode PLC 05 December 2024 5 December 2024 GENinCode Plc ("GENinCode" or the "Company") CARDIO inCode® publication in International...

EARNINGS: Origin Enterprises profit falls; GENinCode loss narrows

The following is a round-up of earnings for London-listed companies, issued on Wednesday and Tuesday and not separate ...

GENinCode PLC Half-year Report

GENinCode PLC 25 September 2024 25 September 2024 GENinCode Plc ("GENinCode", the "Company" or the "Group") Interim report First US...

Company description

Genincode Plc is listed in the Coml Physical, Biologcl Resh sector of the London Stock Exchange with ticker GENI. The last closing price for Genincode was 3.55p. Over the last year, Genincode shares have traded in a share price range of 3.20p to 10.125p.

Genincode currently has 176,960,000 shares in issue. The market capitalisation of Genincode is £6.28 million. Genincode has a price to earnings ratio (PE ratio) of -0.90.

Type	Ordinary Share
Share ISIN	GB00BL97B504
Sector	Coml Physical, Biologcl Resh
Bid Price	3.50
Offer Price	3.60
Open	3.55
Shares Traded	193,823
Last Trade	08:00:00

Low - High	3.55 - 3.55
Turnover	2.16M
Profit	-7.02M
EPS - Basic	-0.0396
PE Ratio	-0.90
Market Cap	6.28M

Market Data

News

Trading Tools

Markets

Discover

Hot Features

Follow Feed

Options Flow

Monitor

Genincode Plc (GENI)

GENinCode PLC Holding(s) in Company

GENinCode PLC Holding(s) in Company

GENinCode PLC Holding(s) in Company

GENinCode PLC Result of General Meeting, Issue of Equity and TVR

GENinCode PLC Result of Retail Offer

IN BRIEF: GENinCode raises GBP4.0 million via placing and subscription

GENinCode PLC Result of Placing and Subscription

GENinCode PLC Retail Offer

GENinCode PLC Placing and Subscription

GENinCode shares rally on test inclusion in clinical lab fee schedule

GENinCode PLC CARDIO inCode Lab Fee Update & Catalonia Launch

GENinCode PLC Partnership with Genesupport SA for the ROCA® Test

GENinCode PLC CARDIO inCode® publication & Trading Update

EARNINGS: Origin Enterprises profit falls; GENinCode loss narrows

GENinCode PLC Half-year Report

Your Recent History

Company

Business

Popular

Get The App

Trending Now

Toplists

Market Data

News

Trading Tools

Markets

Discover

Hot Features

Follow Feed

Options Flow

Monitor

Genincode Plc (GENI) Share Chat

Genincode Plc (GENI)

News Insights

Genincode Share Discussion Threads

News

GENinCode PLC Holding(s) in Company

GENinCode PLC Holding(s) in Company

GENinCode PLC Holding(s) in Company

GENinCode PLC Result of General Meeting, Issue of Equity and TVR

GENinCode PLC Result of Retail Offer

IN BRIEF: GENinCode raises GBP4.0 million via placing and subscription

GENinCode PLC Result of Placing and Subscription

GENinCode PLC Retail Offer

GENinCode PLC Placing and Subscription

GENinCode shares rally on test inclusion in clinical lab fee schedule

GENinCode PLC CARDIO inCode Lab Fee Update & Catalonia Launch

GENinCode PLC Partnership with Genesupport SA for the ROCA® Test

GENinCode PLC CARDIO inCode® publication & Trading Update

EARNINGS: Origin Enterprises profit falls; GENinCode loss narrows

GENinCode PLC Half-year Report

Company description

Your Recent History

Company

Business

Popular

Get The App

Go Ad-Free